Press Releases

December 10th, 2019

Five innovative cannabis education courses will be available to students in January 2020 Toronto, Dec. 10, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) cannabis education division, FoliEdge Academy Inc., has entered into a definitive Educational Products Distribution Agreement with Seneca to develop and deliver new courses […]

December 2nd, 2019

TORONTO, December 2, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has reached a definitive Cannabis Material Purchase Agreement (the “Agreement”) on November 29, 2019, with a Canadian Licensed Producer. Under the terms of the Agreement, Aleafia Health will sell 2,840 kg of dried cannabis flower at […]

November 28th, 2019

TORONTO, November 28, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run of medical cannabis oils, for distribution in Australia. The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by Melbourne, Australia […]

November 19th, 2019

TORONTO, November 19, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs. The partner institution announcement and courses launch will occur […]

November 14th, 2019

Health Canada licence amendment doubles licensed processing area  Company can also now produce and sell edibles, topicals and extracts Final site evidence package for Paris Phase II expansion has been submitted TORONTO, November 14, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Emblem Cannabis […]

November 12th, 2019

Ultra low-cost production at $0.08 cost per gram at outdoor facility Average net revenue per gram equivalent of $15.11 for medical cannabis sales Medical cannabis sales up 43% Q/Q, adult-use cannabis sales up 53% Q/Q Active, registered medical cannabis patients increase 48% Q/Q $57M in cash/marketable securities, $83M in working capital Total expenses decrease 30% […]

November 11th, 2019

Cannabinoid content per gram only slightly lower than identical strains grown indoors Critical quality control tests successful Approximately 1,000 kg yield per acre in Zone 1 Expanded 3.7M sq. ft. outdoor site expected to produce approximately 102,000 kg in 2020 at full capacity TORONTO, November 11, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, […]

October 23rd, 2019

TORONTO — October 23, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12, 2019 prior to market open. The Company will also host its Third Quarter Results Call the same day at 8:30 a.m. EST. The call will be […]

October 8th, 2019

TORONTO, October 8, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 […]

October 7th, 2019

Features initial 115,000 kg of dried flower equivalent annual extraction capacity, with ability for further expansion on-site 2,775% increase over Company’s current annual extraction capacity of 4,000 kg Brant County granted full occupancy of expanded facility on October 4 Final stage of securing Licence Amendment underway, with site evidence package to be submitted to Health […]

October 2nd, 2019

TORONTO, October 2, 2019 – The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new Lead Independent Director.  As previously announced on April 4, 2019, the role rotates among independent directors every six months, as determined by a majority […]

September 24th, 2019

Company maintains strong balance sheet with $51 million in cash on hand Construction of Paris Phase II Processing facility expected to be completed in October 2019 Active, registered patients increased to over 10,000, a 42% increase since July Products grown, extracted and exported by Aleafia Health now available to patients in Australia TORONTO, ON, September […]

September 4th, 2019

New property cost $1.2 million and is directly adjacent to current Port Perry Outdoor Grow facility Company subsidiary, Emblem, also closes sale of unused Brant, Ont. property for $8.2 million in net cash TORONTO, ON, September 4, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”)’s wholly owned […]

August 14th, 2019

Q/Q sale of cannabis revenues increase 377% Q/Q gross profit increases to $2.9M from -$0.1M in previous quarter Q/Q expenses decrease 41% Adjusted EBITDA improves to loss of $2.7 million Strong balance sheet with $58M cash on hand 8,861 registered patients at August 13, 2019, from 6,959 at June 30, 2019 Over 65,000 clinic patients […]

August 7th, 2019

TORONTO — August 7, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) will announce its 2019 Second Quarter Financial Results on August 14, 2019 at 7 a.m. EST. The Company will also host its Second Quarter Results Call the same day at 8:30 a.m. EST. The call […]